Search
Scinai Immunotherapeutics Ltd
SCNIAdd to Watchlist
0.270USD
-0.001-0.29%
Close 07/02, 16:00（ET）Quotes delayed by 15 min
956.00KMarket Cap
LossP/E TTM
Financial Health
Currency: USD Updated: 2026-07-02 The current financial score of Scinai Immunotherapeutics Ltd is 6.56, ranking 239 out of 387 in the Biotechnology & Medical Research industry. Its financial status is stable, and its operating efficiency is high.
Financials
6.86
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.15
Total revenue
Operating profit
Total assets
SG&A
Relevant data have not been disclosed by the company yet.
Operational Efficiency
8.64
Cash flow from operating activities
Income after tax
Relevant data have not been disclosed by the company yet.
Growth Potential
3.94
Cash flow from operating activities
Total revenue
Relevant data have not been disclosed by the company yet.
Shareholder Returns
7.20
Free cash flow
Relevant data have not been disclosed by the company yet.